@article{2f0fee3edbff4362abac30381524a4b9,
title = "Breast cancer outcome in relation to bone mineral density and bisphosphonate use: a sub-study of the DATA trial",
keywords = "Breast cancer, Tamoxifen, Aromatase inhibitor, Bone health, Osteoporosis, Bisphosphonates, Survival, Bone metastases, Distant recurrence-free survival, ZOLEDRONIC ACID, POSTMENOPAUSAL WOMEN, IN-VITRO, THERAPY, CELLS, RISK, CHEMOTHERAPY, METASTASIS, MECHANISMS, CLODRONATE",
author = "{van Hellemond}, {Irene E. G.} and Smorenburg, {Carolien H.} and Peer, {Petronella G. M.} and Swinkels, {Astrid C. P.} and Seynaeve, {Caroline M.} and {van der Sangen}, {Maurice J. C.} and Kroep, {Judith R.} and {de Graaf}, Hiltje and Honkoop, {Aafke H.} and Erdkamp, {Frans L. G.} and {van den Berkmortel}, {Franchette W. P. J.} and {de Roos}, {Wilfred K.} and Linn, {Sabine C.} and Imholz, {Alexander L. T.} and {de Boer}, Maaike and Tjan-Heijnen, {Vivianne C. G.} and {Dutch Breast Canc Res Grp BOOG}",
year = "2020",
month = apr,
doi = "10.1007/s10549-020-05567-9",
language = "English",
volume = "180",
pages = "675--685",
journal = "Breast Cancer Research and Treatment",
issn = "0167-6806",
publisher = "Springer, Cham",
number = "3",
}